Across TCGA pan-cancer cohorts, VN1R10P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated VN1R10P data layer compared with 2 for mutation status.
The strongest signal is observed in thyroid carcinoma (THCA), where higher VN1R10P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated VN1R10P expression acts as an unfavorable survival marker, although some lineages such as PCPG show a favorable association.
THCA, KICH, and KIRC are the cancer types where VN1R10P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.